Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104). (Q46150918)
Jump to navigation
Jump to search
scientific article published on 22 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104). |
scientific article published on 22 January 2009 |
Statements
1 reference
Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104). (English)
1 reference
K Takeda
1 reference
S Negoro
1 reference
T Tamura
1 reference
Y Nishiwaki
1 reference
S Kudoh
1 reference
S Yokota
1 reference
K Matsui
1 reference
H Semba
1 reference
K Nakagawa
1 reference
Y Takada
1 reference
M Ando
1 reference
T Shibata
1 reference
N Saijo
1 reference
22 January 2009
1 reference
1 reference
20
1 reference
5
1 reference
835-841
1 reference
Identifiers
1 reference
1 reference